Importance of Hematuria as a Biomarker for IgA Nephropathy
In this podcast, we will discuss the value of hematuria in IgA Nephropathy prognostication and treatment decision making. Read More
- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
IgA Nephropathy
A Targeted Approach for Immunoglobulin-A Nephropathy
Dr. Srinivasan will discuss the four hit pathogenic process of IgA nephropathy, including the role of galactose deficient immunoglobulin-A1 (Gd-IgA1) and A-proliferation inducing ligand (APRIL). Read More4 Part IgAN Experience
An innovative, four-part educational experience designed to immerse healthcare professionals in the evolving landscape of IgA Nephropathy (IgAN) through interactive technology, evidence-based literature, real-world case studies, and high-impact educational tools. Read MoreFrom Diagnosis to Management in IgA Nephropathy: How Health Literacy Shapes the Patient Journey
Learn about health literacy and how it impacts patients with CKD including IgAN. Dr. Velez will share her expertise as a nephrologist treating patients with IgAN as well as discuss… Read More4-Part IgAN Experience: An Immersive, Interactive Dinner Series Brought to You by NephU
Step into an educational journey designed to deepen your understanding of IgA Nephropathy (IgAN) through an engaging, multi-format learning experience—powered by cutting-edge tools and real-world insights. Read MoreIgA Nephropathy – From Pathogenesis to Current Management
This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide. Read MoreIgA Nephropathy – From Pathogenesis to Current Management
This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide. Read MoreIgA Nephropathy – From Pathogenesis to Current Management
This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide. Read MoreIgA Nephropathy – From Pathogenesis to Current Management
This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide. Read MoreThe Immunomodulating Role of B-cells in IgA Nephropathy – Focus on APRIL
This webinar will explore how B-cell biology, including the role of APRIL (A Proliferation-Inducing Ligand), informs our understanding of IgAN and opens new avenues for therapeutic intervention. Read MoreNephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the kidney health community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2025 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
